$32.36
0.270.84%
At Close: -
$32.36
00.00%
After Hours: Jul 19, 5:07 PM EDT
15 minutes delayed
Collegium Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Collegium Pharmaceutical using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
COLL | Collegium Pharmaceutical | $1.26 | $1.46 | — | — | $135.55M | $143.03M | — | — | 08/01/2024 | Get Alert |
COLL | Collegium Pharmaceutical | $1.32 | $0.75 | $1.45 | 93.33% | $144.77M | $147.49M | $144.92M | -1.74% | 05/09/2024 | Get Alert |
COLL | Collegium Pharmaceutical | $1.09 | $0.66 | $1.58 | 139.39% | $129.62M | $147.82M | $149.75M | 1.30% | 02/22/2024 | Get Alert |
COLL | Collegium Pharmaceutical | $1.10 | $0.52 | $1.34 | 157.69% | $127.01M | $138.53M | $136.71M | -1.31% | 11/07/2023 | Get Alert |
COLL | Collegium Pharmaceutical | $0.33 | $1.22 | $1.26 | 3.28% | $123.55M | $137.98M | $135.55M | -1.76% | 08/03/2023 | Get Alert |
COLL | Collegium Pharmaceutical | $0.42 | $0.31 | $1.32 | 325.81% | $83.75M | $138.47M | $144.77M | 4.55% | 05/04/2023 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.51 | -$0.14 | $1.09 | 878.57% | $27.36M | $125.19M | $129.62M | 3.54% | 02/23/2023 | Get Alert |
COLL | Collegium Pharmaceutical | $0.22 | -$0.13 | $1.10 | 946.15% | $78.84M | $124.45M | $127.01M | 2.06% | 11/03/2022 | Get Alert |
COLL | Collegium Pharmaceutical | $0.27 | $1.45 | $0.33 | -77.24% | $82.94M | $121.80M | $123.55M | 1.44% | 08/04/2022 | Get Alert |
COLL | Collegium Pharmaceutical | $0.41 | $0.90 | $0.42 | -53.33% | $87.72M | $78.88M | $83.75M | 6.18% | 05/10/2022 | Get Alert |
COLL | Collegium Pharmaceutical | $0.20 | $1.04 | -$0.51 | -149.04% | $76.27M | $81.61M | $27.36M | -66.47% | 02/24/2022 | Get Alert |
COLL | Collegium Pharmaceutical | $0.32 | — | $0.22 | — | $79.18M | $84.89M | $78.84M | -7.12% | 11/04/2021 | Get Alert |
COLL | Collegium Pharmaceutical | $0.23 | $0.36 | $0.27 | -25.00% | $78.06M | $84.77M | $82.94M | -2.16% | 08/05/2021 | Get Alert |
COLL | Collegium Pharmaceutical | $0.01 | $0.30 | $0.41 | 36.67% | $76.51M | $81.87M | $87.72M | 7.15% | 05/06/2021 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.07 | $0.29 | $0.20 | -31.03% | $74.20M | $77.41M | $76.27M | -1.47% | 02/25/2021 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.18 | $0.22 | $0.32 | 45.45% | $72.94M | $77.43M | $79.18M | 2.25% | 11/05/2020 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.14 | $0.20 | $0.23 | 15.00% | $75.04M | $74.40M | $78.06M | 4.92% | 08/05/2020 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.29 | $0.37 | $0.01 | -97.30% | $74.52M | $77.08M | $76.51M | -0.74% | 05/07/2020 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.33 | -$0.10 | -$0.07 | 30.00% | $73.43M | $73.33M | $74.20M | 1.19% | 02/27/2020 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.25 | -$0.15 | -$0.18 | -20.00% | $70.18M | $74.46M | $72.94M | -2.04% | 11/06/2019 | Get Alert |
COLL | Collegium Pharmaceutical | -$0.15 | -$0.19 | -$0.14 | 26.32% | $73.06M | $75.82M | $75.04M | -1.03% | 08/07/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $1.45 | $0.75 | 93.3 % |
Dec 2023 | 2024-02-22 | $1.58 | $0.66 | 139.4 % |
Sep 2023 | 2023-11-07 | $1.34 | $0.52 | 157.7 % |
Jun 2023 | 2023-08-03 | $1.26 | $1.22 | 3.28 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $144.92M | $147.49M | -1.74 % |
Dec 2023 | 2024-02-22 | $149.75M | $147.82M | 1.30 % |
Sep 2023 | 2023-11-07 | $136.71M | $138.53M | -1.31 % |
Jun 2023 | 2023-08-03 | $135.55M | $137.98M | -1.76 % |
Collegium Pharmaceutical (COLL) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $1.45, which beat the estimate of $0.75.
The Actual Revenue was $144.9M, which missed the estimate of $147.5M.
Browse earnings estimates, EPS, and revenue on all stocks.